MetLife Investment Management, LLC
Position in ABUS — Arbutus Biopharma Corp
CIK 1529735
Whippany, NJ
Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$452,884
+$88,074 QoQ
Shares Held
94,351
+16.4% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 175 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. ABUS ranks #129 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in ABUS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $452,884 | 94,351 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $364,810 | 81,069 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $352,265 | 73,236 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $398,839 | 87,850 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $274,286 | 88,766 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $310,215 | 88,887 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $267,002 | 81,652 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $314,587 | 81,711 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $252,486 | 81,711 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $159,629 | 61,872 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $147,452 | 58,981 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $119,731 | 58,981 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $135,656 | 58,981 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $178,712 | 58,981 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $102,834 | 44,135 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $111,650 | 58,456 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $95,240 | 35,144 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $118,091 | 39,628 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $38,822 | 9,980 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $128,880 | 30,042 | Shares | Defined | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||